Interaction of human immunodeficiency virus type 1 Vif with APOBEC3G is not dependent on serine/ threonine phosphorylation status

Journal of General Virology

Volumn 93, Issue PART 11, 2012, Pages 2425-2430

  Kopietz, Ferdinand ^a   Vasudevan, Ananda Ayyappan Jaguva ^b   Krämer, Melanie ^b   Muckenfuss, Heide ^a   Sanzenbacher, Ralf ^a   Cichutek, Klaus ^a   Flory, Egbert ^a   Münk, Carsten ^b  

^a PAUL EHRLICH INSTITUT   (Germany)

^b Department of Orthopedic Surgery   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHORUS 32; SERINE; THREONINE; VIF PROTEIN;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTIDINE DEAMINASE; GENE EXPRESSION REGULATION; HEK293 CELLS; HIV-1; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHOSPHORYLATION; POINT MUTATION; SERINE; THREONINE; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84867517494     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.043273-0     Document Type: Article

References (38)

1. Courcoul, M., Patience, C., Rey, F., Blanc, D., Harmache, A., Sire, J., Vigne, R. & Spire, B. (1995). Peripheral blood mononuclear cells produce normal amounts of defective Vif-human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J Virol 69, 2068-2074.
2. Dang, Y., Wang, X., Zhou, T., York, I. A. & Zheng, Y. H. (2009). Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization. J Virol 83, 8544-8552.
3. Dang, Y., Davis, R. W., York, I. A. & Zheng, Y. H. (2010a). Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity. J Virol 84, 5741-5750.
4. Dang, Y., Wang, X., York, I. A. & Zheng, Y. H. (2010b). Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity. J Virol 84, 8561-8570.
5. Demorest, Z. L., Li, M. & Harris, R. S. (2011). Phosphorylation directly regulates the intrinsic DNA cytidine deaminase activity of activationinduced deaminase and APOBEC3G protein. J Biol Chem 286, 26568-26575.
6. Donahue, J. P., Vetter, M. L., Mukhtar, N. A. & D'Aquila, R. T. (2008). The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation. Virology 377, 49-53.
7. Donello, J. E., Beeche, A. A., Smith, G. J., III, Lucero, G. R. & Hope, T. J. (1996). The hepatitis B virus posttranscriptional regulatory element is composed of two subelements. J Virol 70, 4345-4351.
8. Fisher, A. G., Ensoli, B., Ivanoff, L., Chamberlain, M., Petteway, S., Ratner, L., Gallo, R. C. & Wong-Staal, F. (1987). The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237, 888-893.
9. Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A. & Sodroski, J. (1992). Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J Virol 66, 6489-6495.
10. He, Z., Zhang, W., Chen, G., Xu, R. & Yu, X. F. (2008). Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. J Mol Biol 381, 1000-1011.
11. Kao, S., Khan, M. A., Miyagi, E., Plishka, R., Buckler-White, A. & Strebel, K. (2003). The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. J Virol 77, 11398-11407.
12. Kao, S., Miyagi, E., Khan, M. A., Takeuchi, H., Opi, S., Goila-Gaur, R. & Strebel, K. (2004). Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells. Retrovirology 1, 27.
13. Kao, S., Goila-Gaur, R., Miyagi, E., Khan, M. A., Opi, S., Takeuchi, H. & Strebel, K. (2007). Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif. Virology 369, 329-339.
14. Luo, K., Xiao, Z., Ehrlich, E., Yu, Y., Liu, B., Zheng, S. & Yu, X. F. (2005). Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc Natl Acad Sci U S A 102, 11444-11449.
15. Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H. & Landau, N. R. (2003). Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31.
16. Marin, M., Rose, K. M., Kozak, S. L. & Kabat, D. (2003). HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9, 1398-1403.
17. Mehle, A., Goncalves, J., Santa-Marta, M., McPike, M. & Gabuzda, D. (2004). Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev 18, 2861-2866.
18. Mehle, A., Strack, B., Ancuta, P., Zhang, C., McPike, M. & Gabuzda, D. (2004). Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J Biol Chem 279, 7792-7798.
19. Mehle, A., Thomas, E. R., Rajendran, K. S. & Gabuzda, D. (2006). A zinc-binding region in Vif binds Cul5 and determines cullin selection. J Biol Chem 281, 17259-17265.
20. Opi, S., Kao, S., Goila-Gaur, R., Khan, M. A., Miyagi, E., Takeuchi, H. & Strebel, K. (2007). Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant. J Virol 81, 8236-8246.
21. Pery, E., Rajendran, K. S., Brazier, A. J. & Gabuzda, D. (2009). Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif. J Virol 83, 2374-2381.
22. Russell, R. A. & Pathak, V. K. (2007). Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. J Virol 81, 8201-8210.
23. Santa-Marta, M., da Silva, F. A., Fonseca, A. M. & Goncalves, J. (2005). HIV-1 Vif can directly inhibit apolipoprotein B mRNAediting enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation. J Biol Chem 280, 8765-8775.
24. Sheehy, A. M., Gaddis, N. C. & Malim, M. H. (2003). The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9, 1404-1407.
25. Shirakawa, K., Takaori-Kondo, A., Yokoyama, M., Izumi, T., Matsui, M., Io, K., Sato, T., Sato, H. & Uchiyama, T. (2008). Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat Struct Mol Biol 15, 1184-1191.
26. Stanley, B. J., Ehrlich, E. S., Short, L., Yu, Y., Xiao, Z., Yu, X. F. & Xiong, Y. (2008). Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. J Virol 82, 8656-8663.
27. Stopak, K., de Noronha, C., Yonemoto, W. & Greene, W. C. (2003). HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 12, 591-601.
28. Strebel, K., Daugherty, D., Clouse, K., Cohen, D., Folks, T. & Martin, M. A. (1987). The HIV A (sor) gene product is essential for virus infectivity. Nature 328, 728-730.
29. von Schwedler, U., Song, J., Aiken, C. & Trono, D. (1993). Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol 67, 4945-4955.
30. Wolfe, L. S., Stanley, B. J., Liu, C., Eliason, W. K. & Xiong, Y. (2010). Dissection of the HIV Vif interaction with human E3 ubiquitin ligase. J Virol 84, 7135-7139.
31. Xiao, Z., Ehrlich, E., Yu, Y., Luo, K., Wang, T., Tian, C. & Yu, X. F. (2006). Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif. Virology 349, 290-299.
32. Xiao, Z., Xiong, Y., Zhang, W., Tan, L., Ehrlich, E., Guo, D. & Yu, X. F. (2007). Characterization of a novel Cullin5 binding domain in HIV-1 Vif. J Mol Biol 373, 541-550.
33. Yang, X. & Gabuzda, D. (1998). Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein. J Biol Chem 273, 29879-29887.
34. Yang, X., Goncalves, J. & Gabuzda, D. (1996). Phosphorylation of Vif and its role in HIV-1 replication. J Biol Chem 271, 10121-10129.
35. Yang, S., Sun, Y. & Zhang, H. (2001). The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle. J Biol Chem 276, 4889-4893.
36. Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P. & Yu, X. F. (2003). Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060.
37. Yu, Y., Xiao, Z., Ehrlich, E. S., Yu, X. & Yu, X. F. (2004). Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev 18, 2867-2872.
38. Zielonka, J., Marino, D., Hofmann, H., Yuhki, N., Löchelt, M. & Münk, C. (2010). Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids. J Virol 84, 7312-7324.